Insider · CIK 0001770191
Andrew S. Davis
Files at SILK (Silk Road Medical Inc). First filing Mar 5, 2024, latest Jul 8, 2024.
In brief
Andrew S. Davis files SEC Form 4 as officer at SILK (Silk Road Medical Inc). Since Mar 5, 2024, Andrew S. Davis has reported 0 open-market buys worth $0 and 2 open-market sells worth $96k, the latest filed on Jul 8, 2024.
A track record needs three past buys with six months of prices behind them; Andrew S. Davis has 0, so none is measured yet.
The newest scored trade: sold $1,782 of SILK on Jul 3, 2024, filed Jul 8, 2024, scored 15 (weak).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | SILKsell Silk Road Medical Inc | $1,782 66 shares | -0% | - | |
| 40Moderate | Silk Road Medical Inc | $94k 5,481 shares | -2% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jul 3, 2024 | SILK Silk Road Medical Inc | 66 0.00% of outstanding | $1,782 | Jul 3, 2024 | none |
| Mar 5, 2024 | SILK Silk Road Medical Inc | 5,481 0.01% of outstanding | $94k | Mar 5, 2024 | none |
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 17, 2024 | SILK Silk Road Medical Inc | DDisposition to issuer Common Stock | -290,077 | - | - | 0 | Sep 18, 2024 |
| Sep 17, 2024 | SILK Silk Road Medical Inc | AGrant or award Common Stock | +42,218 | $0.00 | $0 | 42,218 | Sep 18, 2024 |
| Sep 17, 2024 | SILK Silk Road Medical Inc | DDisposition to issuer Common Stock | -42,218 | - | - | 0 | Sep 18, 2024 |
| Sep 17, 2024 | SILK Silk Road Medical Inc | DDisposition to issuer Employee Stock Option (right to buy)derivative | -22,033 | $25.90 | $571k | 0 | Sep 18, 2024 |
| Sep 17, 2024 | SILK Silk Road Medical Inc | DDisposition to issuer Employee Stock Option (right to buy)derivative | -62,958 | $22.77 | $1.4M | 0 | Sep 18, 2024 |
| Sep 17, 2024 | SILK Silk Road Medical Inc | DDisposition to issuer Employee Stock Option (right to buy)derivative | -1,853 | $21.39 | $40k | 0 | Sep 18, 2024 |
| Sep 17, 2024 | SILK Silk Road Medical Inc | DDisposition to issuer Employee Stock Option (right to buy)derivative | -33,220 | $7.50 | $249k | 0 | Sep 18, 2024 |
| May 20, 2024 | SILK Silk Road Medical Inc | AGrant or award Common Stock | +2,000 | $7.05 | $14k | 289,773 | Jul 8, 2024 |
| Jul 3, 2024 | SILK Silk Road Medical Inc | SOpen-market sale Common Stock | -66 | $27.00 | $1,782 | 289,707 | Jul 8, 2024 |
| Mar 1, 2024 | SILK Silk Road Medical Inc | AGrant or award Common Stock | +62,201 | $0.00 | $0 | 293,254 | Mar 5, 2024 |
| Mar 5, 2024 | SILK Silk Road Medical Inc | SOpen-market sale Common Stock | -5,481 | $17.17 | $94k | 287,773 | Mar 5, 2024 |
Questions about Andrew S. Davis
Answered from the filings on this page, as of the latest one.
Is Andrew S. Davis buying or selling?
Not in the last 12 months. Andrew S. Davis's latest open-market trade on SEC Form 4 was sold $1,782 of SILK on Jul 3, 2024.
How did Andrew S. Davis's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Andrew S. Davis has 0.
Where does Andrew S. Davis file Form 4?
Andrew S. Davis has filed Form 4 at SILK (Silk Road Medical Inc) as Chief Commercial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.